STAT1-mediated interferon signatures are associated with preclinical JAK inhibitor sensitivity in T-ALL.

INTRODUCTION: Prolidase deficiency is a rare autosomal recessive disorder caused by variants in the PEPD gene. Patients usually have multi-organ involvement and a wide range of clinical features including recurrent skin ulcers, dysmorphic facial features, recurrent infections, intellectual disability, and splenomegaly. Studies have shown that patients with prolidase deficiency may have hepatic manifestations including hepatomegaly and abnormal liver enzymes. However, there is no detailed description of liver disease in this patient population.

CASE PRESENTATION: Here, we present 3 patients with prolidase deficiency with varying extents of hepatic involvement.

CONCLUSION: Prolidase deficiency patients with liver disease should be followed up long term to understand more about the pathophysiology and the impact of liver disease on long-term outcomes.